Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Medical Molecular Morphology|November 22, 2023
Overexpression of SerpinB9 in non-seminomatous germ cell tumorsToshiki Anami, Yuki Ibe, Lianbo Li, et al.
Medical Molecular Morphology|July 9, 2017
CD163-positive cancer cells are potentially associated with high malignant potential in clear cell renal cell carcinomaChaoya Ma, Hasita Horlad, Koji Ohnishi, et al.
Medical Molecular Morphology|March 24, 2025
Aging potentially reduces CD169 expression in sinus macrophages of pelvic lymph nodesYuki Ibe, Yojiro Ozaki, Toshiki Anami, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2022
Aging-associated and CD4 T-cell-dependent ectopic CXCL13 activation predisposes to anti-PD-1 therapy-induced adverse eventsHirotake Tsukamoto, Yoshihiro Komohara, Yusuke Tomita, et al.
Clinical & Translational Immunology|November 20, 2024
The contribution of the CRP/CD64 axis to renal cancer progression by inducing protumor activation of tumor-associated macrophagesCheng Pan, Yukio Fujiwara, Hiromu Yano, et al.
Medical Molecular Morphology|June 17, 2021
High T-cell infiltration in tumor tissue and younger age predict the response to pembrolizumab in recurrent urothelial cancerToshiki Anami, Yoshihiro Komohara, Yuji Miura, et al.
Microbiology and Immunology|March 28, 2023
Predictive value of CXCL10 for the occurrence of immune-related adverse events in patient with renal cell carcinomaYuji Miura, Takanobu Motoshima, Toshiki Anami, et al.
Cancer Genomics & Proteomics|December 27, 2024
Immunohistochemical Analysis of a1-Acid Glycoprotein and Tumor Associated Macrophages in Clear Cell Renal Cell CarcinomaAyano Ezaki, Hiromu Yano, Cheng Pan, et al.
BMC Urology|January 15, 2017
PD-L1 expression in papillary renal cell carcinomaTakanobu Motoshima, Yoshihiro Komohara, Chaoya Ma, et al.
Pageof 5